Skip to main content

Table 5 GLM model for 12-week self-reported quit; adjusted odds ratios with 95 % confidence intervals (CI) and significance results

From: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service

Variable Level Quit rate – n/N (%) Odds ratio (95 % CI) Wald (d.f.) p-value
Sex     8.9 (1) 0.003
Male 905/3055 (29.6 %) 1   
Female 996/3904 (25.5 %) 0.84 (0.76–0.94)   0.003
Region     334.3 (3) <0.001
East Sussex 702/3773 (18.6 %) 1   
Sandwell 913/2331 (39.2 %) 3.28 (2.89–3.73)   <0.001
Walsall 37/140 (26.4 %) 1.50 (1.01–2.22)   0.04
Worcestershire 249/715 (34.8 %) 2.29 (1.89–2.77)   <0.001
Age     82.7 (4) <0.001
12–19 89/426 (20.9 %) 1   
20–29 211/2041 (20.3 %) 1.47 (1.08–2.01)   0.015
30–49 829/2963 (28.0 %) 2.23 (1.68–2.95)   <0.001
50–69 661/2158 (30.6 %) 2.72 (2.04–3.63)   <0.001
70+ 111/371 (29.9 %) 3.18 (2.22–4.56)   <0.001
Counselling     11.8 (6) 0.07
One-to-one 1479/5666 (26.1 %) 1   
Drop-in 130/350 (37.1 %) 1.43 (1.09–1.87)   0.01
GP 125/326 (38.3 %) 1.05 (0.81–1.36)   0.7
Pharmacy 68/207 (32.9 %) 1.17 (0.86–1.59)   0.3
Nurse 35/165 (21.2 %) 0.80 (0.54–1.19)   0.3
Telephone 53/185 (28.6 %) 1.13 (0.81–1.59)   0.5
Other 11/57 (19.3 %) 0.57 (0.28–1.17)   0.1
Treatment     175.8 (1) <0.001
NRT 1513/6085 (24.9 %) 1   
Varenicline 388/874 (44.4 %) 2.87 (2.46–3.35)   <0.001